These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35093011)

  • 1. Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units.
    Matusik E; Lemtiri J; Wabont G; Lambiotte F
    BMC Nephrol; 2022 Jan; 23(1):48. PubMed ID: 35093011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
    Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
    Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
    Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
    Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria.
    Moriyama B; Henning SA; Neuhauser MM; Danner RL; Walsh TJ
    Ann Pharmacother; 2009 Jul; 43(7):1324-37. PubMed ID: 19584386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Renal Replacement Therapy Dosing in Critically Ill Patients: A Quality Improvement Initiative.
    Griffin BR; Thomson A; Yoder M; Francis I; Ambruso S; Bregman A; Feller M; Johnson-Bortolotto S; King C; Bonnes D; Dufficy L; Wu C; Bansal A; Tad-Y D; Faubel S; Jalal D
    Am J Kidney Dis; 2019 Dec; 74(6):727-735. PubMed ID: 31540789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of current practice for β-lactam therapeutic drug monitoring in French ICUs in 2021: a nationwide cross-sectional survey.
    Tritscher P; Delannoy M; Agrinier N; Charmillon A; Degand N; Dellamonica J; Roger C; Leone M; Scala-Bertola J; Novy E
    J Antimicrob Chemother; 2022 Sep; 77(10):2650-2657. PubMed ID: 36059108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-lactam antibiotic concentrations during continuous renal replacement therapy.
    Beumier M; Casu GS; Hites M; Seyler L; Cotton F; Vincent JL; Jacobs F; Taccone FS
    Crit Care; 2014 May; 18(3):R105. PubMed ID: 24886826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
    Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
    Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).
    Abdulla A; Dijkstra A; Hunfeld NGM; Endeman H; Bahmany S; Ewoldt TMJ; Muller AE; van Gelder T; Gommers D; Koch BCP
    Crit Care; 2020 Sep; 24(1):558. PubMed ID: 32933574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
    Dhaese S; Van Vooren S; Boelens J; De Waele J
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A survey of beta-lactam antibiotics and vancomycin dosing strategies in intensive care units and general wards in Belgian hospitals.
    Buyle FM; Decruyenaere J; De Waele J; Tulkens PM; Van Audenrode T; Depuydt P; Claeys G; Robays H; Vogelaers D
    Eur J Clin Microbiol Infect Dis; 2013 Jun; 32(6):763-8. PubMed ID: 23271675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study protocol for ADAPT-TDM: A beta-lactam antibiotic Dose AdaPtation feasibility randomised controlled Trial using Therapeutic Drug Monitoring.
    Pai Mangalore R; Chai MG; Pope J; Lee SJ; Padiglione A; Diehl A; Roberts L; Sim K; Rawson-Harris P; Wicha S; Schneider HG; Peel TN; Jenney A; Ayton D; Peleg AY; Udy AA
    BMJ Open; 2024 Jul; 14(6):e083635. PubMed ID: 38951004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and Pharmacodynamics of Extended-Infusion Cefepime in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Prospective, Open-Label Study.
    Philpott CD; Droege CA; Droege ME; Healy DP; Courter JD; Ernst NE; Harger NJ; Foertsch MJ; Winter JB; Carter KE; Van Fleet SL; Athota K; Mueller EW
    Pharmacotherapy; 2019 Nov; 39(11):1066-1076. PubMed ID: 31549737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Monte Carlo Simulation Approach for Beta-Lactam Dosing in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.
    Jang SM; Gharibian KN; Lewis SJ; Fissell WH; Tolwani AJ; Mueller BA
    J Clin Pharmacol; 2018 Oct; 58(10):1254-1265. PubMed ID: 29746711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.
    Seyler L; Cotton F; Taccone FS; De Backer D; Macours P; Vincent JL; Jacobs F
    Crit Care; 2011; 15(3):R137. PubMed ID: 21649882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ONTAI study - a survey on antimicrobial dosing and the practice of therapeutic drug monitoring in German intensive care units.
    Liebchen U; Paal M; Scharf C; Schroeder I; Grabein B; Zander J; Siebers C; Zoller M
    J Crit Care; 2020 Dec; 60():260-266. PubMed ID: 32932111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal.
    Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA
    Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators.
    Uchino S; Bellomo R; Morimatsu H; Morgera S; Schetz M; Tan I; Bouman C; Macedo E; Gibney N; Tolwani A; Oudemans-van Straaten H; Ronco C; Kellum JA
    Intensive Care Med; 2007 Sep; 33(9):1563-70. PubMed ID: 17594074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.